Log in to save to my catalogue

Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lu...

Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2165656478

Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice

About this item

Full title

Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice

Publisher

United States: Public Library of Science

Journal title

PloS one, 2019-01, Vol.14 (1), p.e0210225

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The efficacy and safety of osimertinib were demonstrated in clinical trials; however, real-world clinical data, particularly the resistance profile, are limited. Here, we investigated the efficacy, safety, and resistance profile of osimertinib in real-world practice. We reviewed medical records of T790M mutation-positive lung cancer patients who st...

Alternative Titles

Full title

Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2165656478

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2165656478

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0210225

How to access this item